Advertisement China Sky One Medical Receives SFDA Approval For Pain Relief Drugs - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

China Sky One Medical Receives SFDA Approval For Pain Relief Drugs

Geranium to be used to cure chronic eczema, carbuncle, furuncle and small scalds

China Sky One Medical (CSOM) has received approvals from the State Food and Drug Administration (SFDA) in China, for the production of Geranium ointment and Musk liniment for pain relief.

Geranium ointment is used to cure chronic eczema, carbuncle, furuncle and small scalds. Musk liniment is used to relieve the pain from scathe, wound, rheumatism and arthrosis. It can be used to treat skin sores and blood clots.

Yan-Qing Liu, Chairman and CEO, CSOM, said: “We are very pleased to receive SFDA approvals for these two drugs in a timely manner, which we believe will benefit an increasing number of patients in China as a result of the new health care system reforms. We remain confident in our ability to identify drugs that have strong market potential that will enhance our overall portfolio.”